24 February 2018
News and Views
Links and Services
A study in this week's issue of the Lancet investigates 14-day triple, 5-day concomitant, and 10-day sequential therapies for H. pylori infection in Latin America.
Evidence from Europe, Asia, and North America suggests that standard 3-drug regimens of a proton-
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors